Table 6 Three-year survival in the 210 patients with N2-3 disease treated with or without concurrent chemotherapy
No concurrent chemotherapy | With concurrent chemotherapy | P Value | |
|---|---|---|---|
DFS | 74.6 | 81.7 | 0.24 |
MFS | 79.3 | 84 | 0.22 |
OS | 85.8 | 89.3 | 0.71 |
No concurrent chemotherapy | With concurrent chemotherapy | P Value | |
|---|---|---|---|
DFS | 74.6 | 81.7 | 0.24 |
MFS | 79.3 | 84 | 0.22 |
OS | 85.8 | 89.3 | 0.71 |